OXFORD BIOMEDICA ORD GBP0.50OXFORD BIOMEDICA ORD GBP0.50OXFORD BIOMEDICA ORD GBP0.50

OXFORD BIOMEDICA ORD GBP0.50

No trades
See on Supercharts

OXB fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Oxford Biomedica Plc is a biopharmaceutical company, which engages in the research and development of gene and cell therapy. The firm also provides bioprocessing and process development services to third parties. It operates through the following segments: Platform and Product. The Platform segment consists of the revenue generating bioprocessing and process development activities undertaken for third parties. The Product segment includes clinical and preclinical development of in vivo and ex vivo gene and cell therapy products which are owned by the group. The company was founded by Alan J. Kingsman and Susan M. Kingsman in 1995 and is headquartered in Oxford, the United Kingdom.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
OXB has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company